Regulations.gov document
CITIZEN PETITION FOR STAY OF ACTION REGARDING EFFICACY END POINTS OF THE PHASE III…
Other · FDA-2020-P-2180 · posted Nov 12, 2020
Key facts
| Document ID | FDA-2020-P-2180-0005 |
|---|---|
| Title | CITIZEN PETITION FOR STAY OF ACTION REGARDING EFFICACY END POINTS OF THE PHASE III CLINICAL TRIALS OF COVID-19 VACCINES from Siri & Glimstad LLP on behalf of Informed Consent Action Network |
| Document type | Other |
| Subtype | Citizen Petition |
| Agency | FDA |
| Docket | FDA-2020-P-2180 |
| Posted | Nov 12, 2020 |
| Comment period opens | Nov 12, 2020 |
At a glance
- 10–99 Public comments on this docket
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Regulations.gov documents
Regulations.gov holds the rulemaking and other documents federal agencies post for public comment. Only agency documents are published here; public submissions are not.
Source: Regulations.gov (U.S. General Services Administration eRulemaking Program) · Source date: